Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
Upcoming Talks
Connect@CHG Genomics Data Forum: COSMOS: joint vector-pathogen sequencing for mosquito-borne disease using probe capture
Tuesday, 02 June 2026, 10am to 10.30am
PharmacoSTORM super-resolution imaging of non-canonical forms of cannabinoid and dopamine signalling
Tuesday, 02 June 2026, 12pm to 1pm
Methylation states underlying clonal fitness at single cell resolution
Tuesday, 02 June 2026, 1pm to 2pm
Understanding the causes and consequences of epigenetic dysfunction in human disease
Wednesday, 03 June 2026, 10.30am to 11.30am
Genes and Environment in diabetes mellitus : A multi-species approach
Wednesday, 03 June 2026, 12.45pm to 2pm
Latest publications
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.
Journal article
Schulz A. et al, (2026), MAbs, 18
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.
Journal article
van Niekerk L. et al, (2026), MAbs, 18
Spatio-temporal eco-evolutionary dynamics of prey-predator systems with defended and undefended prey
Preprint
Roy S. et al, (2026)